UK researchers fine tune nanogel delivery system

A team of researchers at the Queen Mary University in London has been working on a new nanogel delivery system that can reduce toxicity associated with nanoparticles by engineering the gel to break down once it enters the body.

"There is a wider issue of the toxicity of nanoparticles and so my goal was to develop a polymeric system which is able to break down into its original component once it's in the body," principal investigator Marina Resmini tells The Engineer. The gel can be designed to break down once it encounters a specific enzyme or through temperature change in pH levels. "The advantage of this is the drug would be released but you wouldn't have the issue with the toxicity because they would essentially be decomposed."

Like a lot of drug delivery technologies, Resmini believes the nanogel approach can improve efficacy and safety profiles of existing drugs. The new formulation would also help pharma companies extend their products' shelf life. And Resmini says she's on track to develop this new technology to adjust the rate of release, so a therapy can be engineered into a quick, sustained or slow release product.

- here's the story from The Engineer

Suggested Articles

Armed with microrobots and magnetic fields, Pursue scientists are looking to the future of targeted drug delivery, starting with the colon.

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.